Post-IPO Equity Therapeutics Companies

MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up.

Appili Therapeutics is an anti-infective pharmaceutical development company.

Intensity Therapeutics is a biopharmaceutical company that provides chemotherapy treatment for cancer patients.

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.

LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.

C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.

AtaiBeckley develops innovative mental health treatments that address significant unmet medical needs.

Biomea Fusion is a precision oncology company developing novel small molecules that target aggressive forms of cancer.

Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer

NeurAxis develops neuromodulation therapies to address chronic and debilitating conditions in children.

IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.

Fractyl Health is a biotechnology company that provides curative therapies for metabolic diseases.

Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.

Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.

Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.

Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.

BioVie specializes in the development of innovative solutions for the treatment of neurodegenerative and liver diseases.

Prime Medicine is a biotechnology company that utilizes Prime Editing to modify genetic sequences to treat a wide range of diseases.

Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.

ImmunityBio is a late-stage immunotherapy startup that is developing treatments to drive immunogenic pathways in the fight against cancer.

Gain Therapeutics is a biotech company developing pharmacological chaperones drugs designed to treat rare metabolic disorders.

Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics